The purpose of this study is to compare the safety and efficacy of gonadotropin-releasing hormone (GnRH) antagonist therapy versus placebo in patients with moderate to severe rheumatoid arthritis.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT00667758?cond=%22Arthritis%22&lup_s=07/28/2011&lup_d=30
